期刊
JOURNAL OF LIPOSOME RESEARCH
卷 29, 期 1, 页码 35-43出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/08982104.2017.1410173
关键词
Malaria; artemisinin; combination therapy; nanoliposomes; hemolysis; histopathology; biodistribution
Combination therapy of artemether (ART) and lumefantrine (LUM) is well-established for the treatment of uncomplicated malaria worldwide. Nanoliposomes (NLs) encapsulating both drugs were prepared and freeze-dried. The lyophilized nanoliposomes exhibited high entrapment efficiency of artemether (66.18%), relatively low entrapment efficiency of lumefantrine (53.46%), low average size diameter (125.3nm) and found to be stable at 4 degrees C for 60days without significant change in mean particle diameter and drug entrapment efficiencies. In vitro drug release study has shown initial burst effect and then sustained release pattern over a time period of 30h. In vivo toxicity study was examined by liver and kidney function test as well as histopathological examination. Nanoliposomes showed lower hemolytic potential (approximate to 10%) compared to all the components when studied individually. There was no significant change (p>0.05) in biochemical parametes between control and treated group of animals. Pharmacokinetic data of ART+LUM NLs showed higher the area under the plasma concentration-time curve (AUC) values and prolonged residence time of drug in the blood circulation compared with ART+LUM solution. The tissue distribution demonstrated high uptake of ART+LUM-NLs in RES organs particularly in liver and spleen. Biocompatibility was confirmed by hepato- and nephrotoxicity analysis showed no sign of fibrosis, fatty infiltration, centrilobular necrosis and lymphocyte infiltration confirmed the suitability of developed formulation for treatment of malaria.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据